Discover
OCUL
Ocular Therapeutix, Inc.
9.47
2 x 7.08
2 x 12.22
bid
ask
-
0.35
3.56%
2 @ 04:00 PM
9.70 +0.23 (2.43%)
| Ytd | -21.99% | |
| 1y | 0.11% |
9.44
day range
10.05
6.23
52 week range
16.44
| Open | 9.91 | Prev Close | 9.82 | Low | 9.44 | High | 10.05 | Mkt Cap | 2.07B |
| Vol | 2.18M | Avg Vol | 3.05M | EPS | -1.44 | P/E | N/A | Forward P/E | -6.16 |
| Beta | 0.90 | Short Ratio | 10.57 | Inst. Own | 95.68% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-05 | 50-d Avg | 9.14 | 200-d Avg | 10.39 | 1yr Est | 27.09 |
| Income Statement | |||
| Total Revenue | 10.79M | ||
| Revenues (USD) | 10.79M | ||
| Cost of Revenue | 1.33M | ||
| Gross Profit | 9.46M | ||
| Operating Expenses | 102.80M | ||
| Research and Development Expense | 66.21M | ||
| Selling, General and Administrative Expense | 36.58M | ||
| Operating Income | -93.34M | ||
| Interest Expense | 2.78M | ||
| Net Income | -88.61M | ||
| Net Income Common Stock | -88.61M | ||
| Net Income Common Stock (USD) | -88.61M | ||
| Consolidated Income | -88.61M | ||
| Earnings per Basic Share | -0.40 | ||
| Earnings per Basic Share (USD) | -0.40 | ||
| Earnings per Diluted Share | -0.40 | ||
| Earning Before Interest & Taxes (EBIT) | -85.83M | ||
| Earning Before Interest & Taxes (USD) | -85.83M | ||
| Weighted Average Shares | 224.10M | ||
| Weighted Average Shares Diluted | 224.10M | ||
| Balance Sheet | |||
| Cash and Equivalents | 668.31M | ||
| Cash and Equivalents (USD) | 668.31M | ||
| Trade and Non-Trade Receivables | 24.35M | ||
| Current Assets | 706.00M | ||
| Property, Plant & Equipment Net | 24.92M | ||
| Total Assets | 732.53M | ||
| Debt Current | 3.17M | ||
| Total Debt | 79.46M | ||
| Current Liabilities | 47.68M | ||
| Debt Non-Current | 76.29M | ||
| Total Liabilities | 150.96M | ||
| Accumulated Retained Earnings (Deficit) | -1.25B | ||
| Shareholders Equity | 581.57M | ||
| Shareholders Equity (USD) | 581.57M | ||
| Assets Non-Current | 26.53M | ||
| Total Debt (USD) | 79.46M | ||
| Deferred Revenue | 14.00M | ||
| Inventory | 3.74M | ||
| Liabilities Non-Current | 103.27M | ||
| Trade and Non-Trade Payables | 8.03M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 1.28M | ||
| Net Cash Flow from Financing | 294.00K | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | -70.36M | ||
| Capital Expenditure | -4.66M | ||
| Issuance (Purchase) of Equity Shares | 294.00K | ||
| Net Cash Flow from Investing | -4.66M | ||
| Net Cash Flow from Operations | -65.99M | ||
| Share Based Compensation | 15.58M | ||